Dymeclin, the Gene Underlying Dyggve-Melchior-Clausen Syndrome, Encodes a Protein Integral to Extracellular Matrix and Golgi Organization and is Associated with Protein Secretion Pathways Critical in Bone Development

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Dyggve-Melchior-Clausen syndrome (DMC), a severe autosomal recessive skeletal disorder with mental retardation, is caused by mutation of the gene encoding Dymeclin (DYM). Employing patient fibroblasts with mutations characterized at the genomic and, for the first time, transcript level, we identified profound disruption of Golgi organization as a pathogenic feature, resolved by transfection of heterologous wild-type Dymeclin. Collagen targeting appeared defective in DMC cells leading to near complete absence of cell surface collagen fibers. DMC cells have an elevated apoptotic index (P <0.01) likely due to a stress response contingent upon Golgi-related trafficking defects. We performed spatiotemporal mapping of Dymeclin expression in zebrafish embryos and identified high levels of transcript in brain and cartilage during early development. Finally, in a chondrocyte cDNA library, we identified two novel secretion pathway proteins as Dymeclin interacting partners: GOLM1 and PPIB. Together these data identify the role of Dymeclin in secretory pathways essential to endochondral bone formation during early development. Hum Mutat 32:231-239, 2011. (C) 2011 Wiley-Liss, Inc.
Original languageEnglish
Pages (from-to)231 - 239
Number of pages9
JournalHuman Mutation
Volume32
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Dive into the research topics of 'Dymeclin, the Gene Underlying Dyggve-Melchior-Clausen Syndrome, Encodes a Protein Integral to Extracellular Matrix and Golgi Organization and is Associated with Protein Secretion Pathways Critical in Bone Development'. Together they form a unique fingerprint.

Cite this